SAFETY AND EFFICACY ANALYSIS OF THE LOW DOSE COHORT OF A FIRST-IN-HUMAN PHASE 1/2A TRIAL OF ICM-203 AAV GENE THERAPY FOR OSTEOARTHRITIS

Heald, Alison E; Solomon, Lucian B; Page, Richard; Yum, Young Na; Park, Minsun; Myung, Jayhyuk; Collins, Jamie E; Guermazi, Ali; Kim, Dae-Won

SAFETY AND EFFICACY ANALYSIS OF THE LOW DOSE COHORT OF A FIRST-IN-HUMAN PHASE 1/2A TRIAL OF ICM-203 AAV GENE THERAPY FOR OSTEOARTHRITIS

journal contribution

posted on 2025-05-23, 03:55 authored by Alison E Heald, Lucian B Solomon, Richard PageRichard Page, Young Na Yum, Minsun Park, Jayhyuk Myung, Jamie E Collins, Ali Guermazi, Dae-Won Kim

SAFETY AND EFFICACY ANALYSIS OF THE LOW DOSE COHORT OF A FIRST-IN-HUMAN PHASE 1/2A TRIAL OF ICM-203 AAV GENE THERAPY FOR OSTEOARTHRITIS

History

Journal

Osteoarthritis and Cartilage

Volume

33

Pagination

S447-S447

ISSN

1063-4584

eISSN

1522-9653

Language

English

Publication classification

E3.1 Extract of paper

Publisher

Elsevier BV

Usage metrics

Keywords

Aging Clinical Trials and Supportive Activities Clinical Research Osteoarthritis Arthritis Gene Therapy Genetics Biotechnology

SAFETY AND EFFICACY ANALYSIS OF THE LOW DOSE COHORT OF A FIRST-IN-HUMAN PHASE 1/2A TRIAL OF ICM-203 AAV GENE THERAPY FOR OSTEOARTHRITIS

History

Journal

Volume

Pagination

ISSN

eISSN

Language

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports